Xosomix, a pre-clinical drug discovery company focused on harnessing diagnostic and therapeutic use of exosomes, the critical communication and transport mediators of the body, announced the awarding of phase I SBIR grant from Eunice Kennedy Shriver National Institute of Child Health and Human Development.
October 4, 2022
· 2 min read